Improved immune responses in mice using the novel chitosan adjuvant ViscoGel, with a Haemophilus influenzae type b glycoconjugate vaccine
Authors:
- Anne-Charlotte HällgrenAHAnne-Charlotte Hällgren
- Mats AnderssonMAMats Andersson
- Joakim LangebäckJLJoakim Langebäck
- Louise ZettergrenLZLouise Zettergren
- Julie Nilsen-NygaardJNJulie Nilsen-Nygaard
- Kurt Ingar DragetKDKurt Ingar Draget
- Marianne van HageMHMarianne van Hage
- Alf LindbergALAlf Lindberg
- Guro GafvelinGGGuro Gafvelin
- Hans GrönlundHGHans Grönlund
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Carbohydrate-based immune adjuvantsExpert Review of Vaccines, 2011
- Alum interaction with dendritic cell membrane lipids is essential for its adjuvanticityNature Medicine, 2011
- New adjuvants for human vaccinesCurrent Opinion in Immunology, 2010
- Cutting Edge: Alum Adjuvant Stimulates Inflammatory Dendritic Cells through Activation of the NALP3 InflammasomeThe Journal of Immunology, 2008
- Vaccine adjuvants: The dream becomes realHuman Vaccines, 2008
- Improving vaccine delivery using novel adjuvant systemsHuman Vaccines, 2008
- Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cellsJournal of Experimental Medicine, 2008
- IC31® and IC30, novel types of vaccine adjuvant based on peptide delivery systemsExpert Review of Vaccines, 2007
- Carbohydrate-based particles: a new adjuvant for allergen-specific immunotherapyImmunology, 2002
- Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscleBrain, 2001